Clinical Trial Update: Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas [Phase 1]

View source ↗

Summary

A terminated Phase I/II study evaluating irinotecan in combination with temsirolimus in patients with refractory sarcomas. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Sarcoma | Phase 1 | Status: TERMINATED | Results posted: 2015-09-01